ACE I/D polymorphism is associated with mortality in a cohort study of patients starting with dialysis

Kidney International

Volumn 68, Issue 5, 2005, Pages 2237-2243

  Van Der Sman De Beer, Femke ^a   Verhagen, Claudia ^b   Rombach, Saskia M ^b   Boorsma, Peter ^b   Van Manen, Jeannette G ^b   Korevaar, Johanna C ^b   Van Den Bogaard, Ruud ^b   Boeschoten, Elisabeth W ^b   Krediet, Raymond T ^b   Navis, Gerjan J ^b   Vandenbroucke, Jan P ^b   Dekker, Friedo W ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Angiotensin converting enzyme; Dialysis; End stage renal disease; Mortality; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; CAUCASIAN; COHORT ANALYSIS; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; ETHNOLOGY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAZARD ASSESSMENT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TIME OF DEATH;

AGED; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; PERITONEAL DIALYSIS; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 30944459688     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00681.x     Document Type: Conference Paper

References (34)

1. VAN DIJK PC, JAGER KJ, DE CHARRO F, et al: Renal replacement therapy in Europe: The results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 16:1120-1129, 2001
2. UNITED STATES RENAL DATA SYSTEM: Excerpt from the United States Renal Data System 1999 Annual Data Report. VI. Causes of death in ESRD. Am J Kidney Dis 34:S87-S94, 1999
3. FOLEY RN, PARFREY PS, SARNAK MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112-S119, 1998
4. RIGAT B, HUBERT C, ALHENC-GELAS F, et al: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
5. DANSER AH, SCHALEKAMP MA, BAX WA, et al: Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92:1387-1388, 1995
6. MIZUIRI S, HEMMI H, KUMANOMIDOU H, et al: Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression. Kidney Int 60:1124-1130, 2001
7. CAMBIEN F, POIRIER O, LECERF L, et al: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
8. STAESSEN JA, WANG JG, GINOCCHIO G, et al: The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 15:1579-1592, 1997
9. SAMANI NJ, THOMPSON JR, O'TOOLE L, et al: A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 94:708-712, 1996
10. SAYED-TABATABAEI FA, HOUWING-DUISTERMAAT JJ, VAN DUIJN CM, et al: Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: A meta-analysis. Stroke 34:1634-1639, 2003
11. AGERHOLM-LARSEN B, NORDESTGAARD BG, TYBJAERG-HANSEN A: ACE gene polymorphism in cardiovascular disease: Meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol 20:484-492, 2000
12. NAVIS G, VAN DER KLEIJ FG, DE ZEEUW D, DE JONG PE: Angiotensin-converting enzyme gene I/D polymorphism and renal disease. J Mol Med 77:781-791, 1999
13. HADJADJ S, BELLOUM R, BOUHANICK B, et al: Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: A prospective study. J Am Soc Nephrol 12:541-549, 2001
14. JACOBSEN P, TARNOW L, CARSTENSEN B, et al: Genetic variation in the renin-angiotensin system and progression of diabetic nephropathy. J Am Soc Nephrol 14:2843-2850, 2003
15. OSONO E, KURIHARA S, HAYAMA N, et al: Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease. Am J Kidney Dis 32:725-730, 1998
16. ISHIMITSU T, HOSOYA K, MATSUOKA H: The deletion allele of angiotensin-converting enzyme gene polymorphism as a cardiovascular risk factor in patients undergoing long-term hemodialysis. Ann Intern Med 133:924, 2000
17. LOSITO A, KALIDAS K, SANTONI S, et al: Polymorphism of renin-angiotensin system genes in dialysis patients - Association with cerebrovascular disease. Nephrol Dial Transplant 17:2184-2188, 2002
18. AUCELLA F, MARGAGLIONE M, VIGILANTE M, et al: PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis. Nephrol Dial Transplant 18:1142-1146, 2003
19. WANG AY, CHAN JC, WANG M, et al: Cardiac hypertrophy and remodeling in relation to ACE and angiotensinogen genes genotypes in Chinese dialysis patients. Kidney Int 63:1899-1907, 2003
20. SAKKA Y, BABAZONO T, SATO A, et al: ACE gene polymorphism, left ventricular geometry, and mortality in diabetic patients with end-stage renal disease. Diabetes Res Clin Pract 64:41-49, 2004
21. HIGASHIUESATO Y, TANA T, TOZAWA M, et al: Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and survival in a cohort of chronic hemodialysis patients. Clin Nephrol 58:370-375, 2002
22. ISHIMITSU T, TSUKADA K, OHTA S, et al: Increased cardiovascular risk in long-term hemodialysis patients carrying deletion allele of ACE gene polymorphism. Am J Kidney Dis 44:466-475, 2004
23. JOHANNING GL, JOHNSTON KE, TAMURA T, GOLDENBERG RL: Ethnic differences in angiotensin converting enzyme gene polymorphism. J Hypertens 13:710-711, 1995
24. KOSTER T, ROSENDAAL FR, DE RONDE H, et al: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342:1503-1506, 1993
25. VAN DER MEER FJ, KOSTER T, VANDENBROUCKE JP, et al: The Leiden Thrombophilia Study (LETS). Thromb Haemost 78:631-635, 1997
26. KHAN IH, CATTO GR, EDWARD N, et al: Influence of coexisting disease on survival on renal-replacement therapy. Lancet 341:415-418, 1993
27. MARRE M, JEUNEMAITRE X, GALLOIS Y, et al: Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest 99:1585-1595, 1997
28. ROTHMAN KJ (editor): Epidemiology, New York, Oxford University Press, Inc., 2002, pp 168-180
29. VANDENBROUCKE JP: The history of confounding. Soz Praventivmed 47:216-224, 2002
30. CARDON LR, PALMER LJ: Population stratification and spurious allelic association. Lancet 361:598-604, 2003
31. WACHOLDER S, ROTHMAN N, CAPORASO N: Population stratification in epidemiologic studies of common genetic variants and cancer: Quantification of bias. J Natl Cancer Inst 92:1151-1158, 2000
32. WANG Y, LOCALIO R, REBBECK TR: Evaluating bias due to population stratification in case-control association studies of admixed populations. Genet Epidemiol 27:14-20, 2004
33. MEDEIROS R, VASCONCELOS A, COSTA S, et al: Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer. J Pathol 202:330-335, 2004
34. LIN MT, ALBERTSON TE: Genomic polymorphisms in sepsis. Crit Care Med 32:569-579, 2004